1,564,026 Shares in The Cooper Companies, Inc. $COO Purchased by Manning & Napier Advisors LLC

Manning & Napier Advisors LLC acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 1,564,026 shares of the medical device company’s stock, valued at approximately $128,985,000. Cooper Companies comprises 1.6% of Manning & Napier Advisors LLC’s investment portfolio, making the stock its 18th biggest holding.

A number of other large investors also recently added to or reduced their stakes in COO. Wellington Management Group LLP grew its position in shares of Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares during the period. JANA Partners Management LP acquired a new position in Cooper Companies in the third quarter valued at approximately $166,917,000. Capital World Investors boosted its stake in Cooper Companies by 25.7% in the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after acquiring an additional 2,159,233 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in Cooper Companies by 98.8% in the second quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock valued at $241,120,000 after acquiring an additional 1,683,561 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA grew its holdings in Cooper Companies by 96.9% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock worth $212,519,000 after acquiring an additional 1,525,693 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently weighed in on COO shares. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Weiss Ratings raised Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th. Needham & Company LLC upped their price objective on Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a report on Friday, March 6th. William Blair raised Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Finally, Barclays raised their target price on Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, March 6th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $90.79.

Cooper Companies Trading Down 1.8%

Shares of NASDAQ COO opened at $60.00 on Friday. The Cooper Companies, Inc. has a twelve month low of $59.68 and a twelve month high of $89.83. The stock has a market cap of $11.71 billion, a price-to-earnings ratio of 29.70, a P/E/G ratio of 1.58 and a beta of 0.89. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The company’s fifty day moving average is $71.18 and its 200-day moving average is $76.08.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.